Cargando…
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740118/ https://www.ncbi.nlm.nih.gov/pubmed/35002692 http://dx.doi.org/10.3389/fphar.2021.734443 |
_version_ | 1784629244820717568 |
---|---|
author | Li, Nuannuan Sun, Yiying Fu, Yuanlei Sun, Kaoxiang |
author_facet | Li, Nuannuan Sun, Yiying Fu, Yuanlei Sun, Kaoxiang |
author_sort | Li, Nuannuan |
collection | PubMed |
description | RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenvironment, but also due to the intrinsic obstacles of RNAs. Until now, all kinds of strategies have been developed to improve the performance of RNAs for cancer therapy, especially the nanoparticle-based ones using biogenic materials. They are much more compatible with less toxicity compared to the ones using synthetic polymers, and the most widely studied biogenic materials are oligonucleotides, exosomes, and cell membranes. Particular characteristics make them show different capacities in internalization and endosomal escape as well as specific targeting. In this paper, we systematically summarize the RNA-based nano-delivery systems using biogenic materials for cancer therapy, and we believe this review will provide a valuable reference for researchers involved in the field of biogenic delivery and RNA-based therapies for cancer treatment. |
format | Online Article Text |
id | pubmed-8740118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87401182022-01-08 RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy Li, Nuannuan Sun, Yiying Fu, Yuanlei Sun, Kaoxiang Front Pharmacol Pharmacology RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenvironment, but also due to the intrinsic obstacles of RNAs. Until now, all kinds of strategies have been developed to improve the performance of RNAs for cancer therapy, especially the nanoparticle-based ones using biogenic materials. They are much more compatible with less toxicity compared to the ones using synthetic polymers, and the most widely studied biogenic materials are oligonucleotides, exosomes, and cell membranes. Particular characteristics make them show different capacities in internalization and endosomal escape as well as specific targeting. In this paper, we systematically summarize the RNA-based nano-delivery systems using biogenic materials for cancer therapy, and we believe this review will provide a valuable reference for researchers involved in the field of biogenic delivery and RNA-based therapies for cancer treatment. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8740118/ /pubmed/35002692 http://dx.doi.org/10.3389/fphar.2021.734443 Text en Copyright © 2021 Li, Sun, Fu and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Nuannuan Sun, Yiying Fu, Yuanlei Sun, Kaoxiang RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title | RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title_full | RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title_fullStr | RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title_full_unstemmed | RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title_short | RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy |
title_sort | rna drug delivery using biogenic nanovehicles for cancer therapy |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740118/ https://www.ncbi.nlm.nih.gov/pubmed/35002692 http://dx.doi.org/10.3389/fphar.2021.734443 |
work_keys_str_mv | AT linuannuan rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy AT sunyiying rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy AT fuyuanlei rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy AT sunkaoxiang rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy |